Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27554125 | 1.00 | ALDH1A1 (0.45) | ALDH1A1LMNATSHRTP53FGFR4 | |
| SCHEMBL5327633 | 0.82 | — | — | |
| SCHEMBL8752815 | 0.80 | ALDH1A1 (0.38) | ALDH1A1LMNA | |
| SCHEMBL9499003 | 0.78 | LMNA (0.53) | ALDH1A1LMNATSHRFGFR4ALOX15 | |
| SCHEMBL9498997 | 0.78 | LMNA (0.53) | ALDH1A1LMNATSHRFGFR4ALOX15 | |
| SCHEMBL5181997 | 0.78 | LMNA (0.53) | ALDH1A1LMNATSHRFGFR4ALOX15 | |
| SCHEMBL8664423 | 0.78 | ALDH1A1 (0.45) | ALDH1A1LMNATSHRTP53FGFR4 | |
| Ethylene SCHEMBL27692988 | 0.76 | LMNA (0.50) | ALDH1A1LMNATSHRFGFR4ALOX15 | |
| SCHEMBL8762992 | 0.74 | — | — | |
| SCHEMBL10791806 | 0.74 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRTP53FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9184428-B2 | Non-aqueous electrolytes for lithium ion batteries | UCHICAGO ARGONNE LLC (US) | 2015-11-10 | — | — | US | claimed |
| US-9012096-B2 | Long life lithium batteries with stabilized electrodes | UCHICAGO ARGONNE, LLC (US) | 2015-04-21 | — | — | US | claimed |
| US-7851092-B2 | Redox shuttles for overcharge protection of lithium batteries | U CHICAGO ARGONNE LLC (US) | 2010-12-14 | — | — | US | claimed |
| WO-2006101779-A2 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM ION BATTERIES | THE UNIVERSITY OF CHICAGO (US) | 2006-09-28 | — | — | WO | claimed |
| US-20060210883-A1 | Non-aqueous electrolytes for lithium ion batteries | THE UNIVERSITY OF CHICAGO | 2006-09-21 | — | — | US | claimed |
| WO-2006094069-A2 | NOVEL REDOX SHUTTLES FOR OVERCHARGE PROTECTION OF LITHIUM BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2006-09-08 | — | — | WO | claimed |
| US-20060199080-A1 | Novel redox shuttles for overcharge protection of lithium batteries | THE UNIVERSITY OF CHICAGO | 2006-09-07 | — | — | US | claimed |
| US-20060147809-A1 | Non-aqueous electrolyte of an alkali metal salt, a polar aprotic solvent, and an electrode stabilization additive comprising a linear, branched or cyclic hydrocarbon, other than a spirocyclic hydrocarbon, comprising at least one oxygen atom and at least one aryl, alkenyl or alkynyl group | THE UNIVERSITY OF CHICAGO | 2006-07-06 | — | — | US | claimed |
| US-12021226-B2 | Cathode materials for secondary batteries | UCHICAGO ARGONNE, LLC (US) | 2024-06-25 | — | — | US | disclosed |
| US-11949069-B2 | Lithium ion battery electrolyte additive | NOHMs Technologies, Inc. (US) | 2024-04-02 | — | — | US | disclosed |
| US-20240039046-A1 | MODIFIED DOPO BASED BATTERY ELECTROLYTE ADDITIVES | Sionic Energy, Inc. | 2024-02-01 | — | — | US | disclosed |
| WO-2024026300-A2 | FUNCTIONALIZED CROWN ETHERS FOR LITHIUM-ION BATTERIES | NOHMs Technologies, Inc. (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2024026265-A2 | MODIFIED DOPO-BASED BATTERY ELECTROLYTES | NOHMs Technologies, Inc. (US) | 2024-02-01 | — | — | WO | disclosed |
| US-20240039047-A1 | FUNCTIONALIZED CROWN ETHERS FOR LITHIUM-ION BATTERIES | NOHMs Technologies, Inc. | 2024-02-01 | — | — | US | disclosed |
| US-20070148545-A1 | Electrode materials and lithium battery systems | THE UNIVERSITY OF CHICAGO | 2007-06-28 | — | — | US | disclosed |
| WO-2006101779-A2 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM ION BATTERIES | THE UNIVERSITY OF CHICAGO (US) | 2006-09-28 | — | — | WO | disclosed |
| US-20060210883-A1 | Non-aqueous electrolytes for lithium ion batteries | THE UNIVERSITY OF CHICAGO | 2006-09-21 | — | — | US | disclosed |
| WO-2006094069-A2 | NOVEL REDOX SHUTTLES FOR OVERCHARGE PROTECTION OF LITHIUM BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2006-09-08 | — | — | WO | disclosed |
| US-20060199080-A1 | Novel redox shuttles for overcharge protection of lithium batteries | THE UNIVERSITY OF CHICAGO | 2006-09-07 | — | — | US | disclosed |
| US-20060147809-A1 | Non-aqueous electrolyte of an alkali metal salt, a polar aprotic solvent, and an electrode stabilization additive comprising a linear, branched or cyclic hydrocarbon, other than a spirocyclic hydrocarbon, comprising at least one oxygen atom and at least one aryl, alkenyl or alkynyl group | THE UNIVERSITY OF CHICAGO | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240039047-A1 | FUNCTIONALIZED CROWN ETHERS FOR LITHIUM-ION BATTERIES | CYCS, GALE, CES2 | ALDH1A1 2994/4885LMNA 1590/4885TSHR 2865/4885 |
| US-11949069-B2 | Lithium ion battery electrolyte additive | LSM8, KCNN2, TRMT1L | ALDH1A1 2200/4885LMNA 977/4885TSHR 4698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.